Streetbeat News

Products Services

DKNG

DraftKings (NASDAQ:DKNG) has seen a surge in options activity, with a bearish sentiment prevailing among investors. Analysis of 12 trades shows a split between bullish (41%) and bearish (58%) expectations. Significant trades include both calls and puts with strike prices ranging from $25.0 to $55.0. DraftKings, a leader in online sports and casino gambling, is currently live in multiple states and Canada, and also operates in the NFT space. The stock's current price is $41.15, with analysts giving an average target price of $50.4.

Portfolio Pulse from Benzinga Insights

February 26, 2024 | 8:00 pm

JPM

JPMorgan Chase & Co CEO Jamie Dimon expressed strong optimism about AI, stating it's a real advancement, not mere hype. In a CNBC interview, he highlighted AI's potential to improve lives and even extend longevity. Dimon contrasted AI's current boom with the internet bubble, emphasizing AI's tangible benefits and its critical role in JPMorgan's future. He mentioned JPMorgan's investment in AI research, with 200 people working on large language models (LLMs) to explore their applications, particularly in healthcare, where AI could revolutionize disease prediction and drug invention.

Portfolio Pulse from Adam Eckert

February 26, 2024 | 7:49 pm

SARK

TARK

Zoom Video Communications, Inc (NASDAQ:ZM) is trading flat as it approaches its Q4 earnings, with analysts predicting an EPS of $1.13 on revenues of $1.131 billion. The stock has been in a downtrend, and technical analysis suggests bearish sentiment. Exane BNP Paribas analyst Stefan Slowinski downgraded Zoom to Underperform with a $60 price target. For diversification, traders might consider AXS 2X Innovation ETF (NASDAQ:TARK) or AXS Short Innovation Daily ETF (NASDAQ:SARK), which track the performance of ARK Innovation ETF (NYSE:ARKK) and its inverse, respectively.

Portfolio Pulse from Melanie Schaffer

February 26, 2024 | 7:45 pm

CCJ

Cameco's CEO highlighted the contrast between durable demand and fragile supply in the uranium market at the BMO Conference, reinforcing the company's decade-old message of strong long-term fundamentals due to increasing demand and tight supply.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 7:43 pm

COIN

GOOGL

IWM

MARA

RIOT

TLT

TSLA

Wall Street saw a subdued start to the week with major indices showing little change. The S&P 500 and Nasdaq 100 experienced minor adjustments, while the iShares Russell 2000 ETF (IWM) saw a slight increase. Treasury yields rose, impacting the iShares 20+ Year Treasury Bond ETF (TLT). In the stock market, Tesla (TSLA) and other EV stocks rallied, while Alphabet (GOOGL) fell due to concerns over its Gemini AI tool. Crypto-related stocks like Marathon Digital Holdings (MARA), Coinbase Global (COIN), and Riot Platforms (RIOT) surged alongside Bitcoin. Other notable movements included Palo Alto Networks (PANW) and R1 RCM (RCM) seeing significant gains.

Portfolio Pulse from Piero Cingari

February 26, 2024 | 7:35 pm

ACON

AGTI

AKLI

LUNR

PPC

TRNR

VERO

Pilgrim's Pride Corporation (NASDAQ:PPC) reported better-than-expected Q4 results with a 9.7% year-over-year sales growth to $4.528 billion and an adjusted EPS of 59 cents. Akili, Inc. (NASDAQ:AKLI) shares surged 116% after positive ADHD treatment trial results. Interactive Strength Inc. (NASDAQ:TRNR) rose 41% on a distribution deal with WOODWAY. Agiliti, Inc. (NYSE:AGTI) gained 29% after announcing a private acquisition by THL Partners. Aclarion, Inc. (NASDAQ:ACON), Intuitive Machines, Inc. (NASDAQ:LUNR), and Venus Concept Inc. (NASDAQ:VERO) saw significant share price drops due to various challenges.

Portfolio Pulse from Avi Kapoor

February 26, 2024 | 7:30 pm

SPRY

ARS Pharmaceuticals Inc (NASDAQ:SPRY) announced positive phase 2 results for its lead candidate, neffy, in treating chronic spontaneous urticaria, showing significant improvements in itch, hives, urticaria, and erythema scores. Neffy, an epinephrine nasal spray, was well-tolerated with mild to moderate adverse events. The company plans further studies towards FDA approval for allergic reactions, including anaphylaxis, with SPRY shares rising 5.15% to $8.78.

Portfolio Pulse from Vandana Singh

February 26, 2024 | 7:12 pm

ACON

AKLI

FRPT

HOLO

VERO

ZVSA

Freshpet, Inc. (NASDAQ:FRPT) shares surged 15.5% after reporting Q4 earnings and sales above estimates. Other stocks also moved significantly in Monday's mid-day session, with notable gainers including Akili, Inc. (NASDAQ:AKLI), ZyVersa Therapeutics, Inc. (NASDAQ:ZVSA), and MicroCloud Hologram Inc. (NASDAQ:HOLO), among others. Losers included Aclarion, Inc. (NASDAQ:ACON) and Venus Concept Inc. (NASDAQ:VERO).

Portfolio Pulse from Avi Kapoor

February 26, 2024 | 6:57 pm

General Motors (NYSE:GM) has launched its electric Cadillac Lyriq in France, marking a significant step in its re-entry into the European market. Unlike in the U.S., GM is adopting an online sales model for European customers. The move comes as part of GM's broader strategy to tap into the growing European electric vehicle market, following its initial EV sales in Switzerland. The company plans to expand its electric vehicle offerings in Europe, with Germany expected to see the Lyriq by year-end. GM shares rose 0.62% to $39.88.

Portfolio Pulse from Vandana Singh

February 26, 2024 | 6:46 pm

BYDDY

TSLA

BYD Company Limited is targeting the luxury EV market with its new super EV, the U9, from its luxury brand Yangwang, challenging established brands like Ferrari with its high speed and acceleration. BYD's expansion into Europe includes building its first factory in Hungary, a move supported by Beijing's subsidies. Meanwhile, Tesla Inc faces increased competition from BYD, especially as BYD does not sell its EVs in the U.S. due to tariffs but is expanding globally. General Motors is also re-entering the European market with luxury EVs, starting with the Cadillac Lyriq in France.

Portfolio Pulse from Upwallstreet

February 26, 2024 | 6:44 pm